Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
43 | Publisher: Global Markets Direct
Industry: Healthcare | Report Format: Electronic (PDF)
Hand, Foot And Mouth Disease - Pipeline Review, H2 2014 Summary Global Markets Direct's, 'Hand, Foot And Mouth Disease - Pipeline Review, H2 2014', provides an overview of the Hand, Foot And Mouth Disease's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hand, Foot And Mouth Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hand, Foot And Mouth Disease and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Hand, Foot And Mouth Disease - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Hand, Foot And Mouth Disease and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Hand, Foot And Mouth Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Hand, Foot And Mouth Disease pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Hand, Foot And Mouth Disease - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Hand, Foot And Mouth Disease pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Hand, Foot And Mouth Disease Overview 6 Therapeutics Development 7 Pipeline Products for Hand, Foot And Mouth Disease - Overview 7 Pipeline Products for Hand, Foot And Mouth Disease - Comparative Analysis 8 Hand, Foot And Mouth Disease - Therapeutics under Development by Companies 9 Hand, Foot And Mouth Disease - Pipeline Products Glance 10 Late Stage Products 10 Clinical Stage Products 11 Early Stage Products 12 Hand, Foot And Mouth Disease - Products under Development by Companies 13 Hand, Foot And Mouth Disease - Companies Involved in Therapeutics Development 14 Takeda Pharmaceutical Company Limited 14 CJ CheilJedang Corp. 15 Sinovac Biotech Ltd. 16 iQur Ltd. 17 Sentinext Therapeutics Sdn Bhd 18 Chongqing Zhifei Biological Products Co., Ltd. 19 Hand, Foot And Mouth Disease - Therapeutics Assessment 20 Assessment by Monotherapy Products 20 Assessment by Route of Administration 21 Assessment by Molecule Type 22 Drug Profiles 24 EV-71 Vaccine - Drug Profile 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 INV-21 - Drug Profile 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 hand, foot and mouth (viral like particle) (bivalent) vaccine - Drug Profile 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 hand foot and mouth disease vaccine - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 CJ-40010 - Drug Profile 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 FMDV Vaccine - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Hand, Foot And Mouth Disease - Recent Pipeline Updates 31 Hand, Foot And Mouth Disease - Product Development Milestones 34 Featured News & Press Releases 34 Apr 24, 2014: Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project 34 Feb 26, 2014: Sinovac's EV71 Vaccine Phase III Clinical Trial Results Published in New England Journal of Medicine 34 May 30, 2013: Sinovac Files New Drug Application For EV71 Vaccine And Receives Filing Acceptance From Beijing Drug Administration 35 May 28, 2013: Experimental Vaccine Protects Kids Against Hand, Foot And Mouth Disease, Clinical Trial Shows 36 Apr 18, 2013: Sinovac Announces Presentation Of EV71 Vaccine Phase III Top-Line Results At 13th Annual World Vaccine Congress & Expo 36 Mar 14, 2013: Sinovac Reports Positive Preliminary Top-Line Results From Phase III Clinical Trial For EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease 37 Jun 25, 2012: Sinovac Reports Progress In EV71 Vaccine Phase III Clinical Trial And Commercialization Preparation Status 38 Jun 11, 2012: Sinovac Reports Progress In EV71 Vaccine Phase III Clinical Trial 39 Mar 29, 2012: Sinovac Announces Publication Of Phase I Clinical Data Of EV71 Vaccine For Prevention Of Hand, Foot And Mouth Disease In Journal Vaccine 39 Mar 11, 2012: Inviragen Reports Top-Line Results From Phase I Trial Of INV21 Vaccine For Treatment Of Hand, Foot And Mouth Disease 40 Appendix 42 Methodology 42 Coverage 42 Secondary Research 42 Primary Research 42 Expert Panel Validation 42 Contact Us 43 Disclaimer 43
List of Tables Number of Products under Development for Hand, Foot And Mouth Disease, H2 2014 7 Number of Products under Development for Hand, Foot And Mouth Disease - Comparative Analysis, H2 2014 8 Number of Products under Development by Companies, H2 2014 9 Comparative Analysis by Late Stage Development, H2 2014 10 Comparative Analysis by Clinical Stage Development, H2 2014 11 Comparative Analysis by Early Stage Development, H2 2014 12 Products under Development by Companies, H2 2014 13 Hand, Foot And Mouth Disease - Pipeline by Takeda Pharmaceutical Company Limited, H2 2014 14 Hand, Foot And Mouth Disease - Pipeline by CJ CheilJedang Corp., H2 2014 15 Hand, Foot And Mouth Disease - Pipeline by Sinovac Biotech Ltd., H2 2014 16 Hand, Foot And Mouth Disease - Pipeline by iQur Ltd., H2 2014 17 Hand, Foot And Mouth Disease - Pipeline by Sentinext Therapeutics Sdn Bhd, H2 2014 18 Hand, Foot And Mouth Disease - Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H2 2014 19 Assessment by Monotherapy Products, H2 2014 20 Number of Products by Stage and Route of Administration, H2 2014 21 Number of Products by Stage and Molecule Type, H2 2014 23 Hand, Foot And Mouth Disease Therapeutics - Recent Pipeline Updates, H2 2014 31
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
